Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Oct 04, 2021 10:00 AM - Oct 04, 2021 1:30 PM

(US Eastern Standard Time)

Short Course 1: Differentiating Your Biosimilar From the Crowd

Instructors

Cecil J. Nick, MS

Cecil J. Nick, MS

FTOPRA, Vice President (Technical), Parexel Consulting, United Kingdom

BSc (Hons) in Biochemistry from University of Cape Town. Working in regulatory affairs and clinical development for over 30 years with focus on biological medicines and particular expertise in biosimilars. Joined PAREXEL in 2001 prior to which was with Novo Nordisk Ltd.

Wyatt  Gotbetter, MPA

Wyatt Gotbetter, MPA

Senior Vice President and Worldwide Head, Access Consulting, Parexel , United States

Seasoned life sciences executive and strategy consulting leader experienced in asset and franchise growth strategy and mergers and acquisitions/transactions advisory support. Skilled in leading domestic and global teams in marketing strategy, portfolio management, new product commercialization, and market access. Functional expertise in strategy development, life cycle management, valuation, diligence, and digital health. Therapeutic and technical focus in autoimmune and CNS diseases and drug delivery devices and formulation technologies. Have advised or supported integration of >$40B in life sciences transactions.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.